Evicenter
MarkdownMedical informationP&T meetings
Inaxaplin (VX-147)

APOL1-mediated kidney disease

Launch
Not announced
Last updated
162 sources

Product information and disease descriptionPlace of product in therapyDisease descriptionBurden of APOL1-mediated kidney disease

Economic impact of diagnostic testing

9 evidence topics · 10 sources

List price or Medicare payment rate for APOL1 genotyping

No evidence found.